August 2024 Newsletter Issue
The Yale Conference for Alcohol Research and Education (YCARE) 2024 will take place on Saturday, October 19, 2024. The event is a dynamic day of learning, interaction, and collaboration focused on the theme of alcohol research. This year’s in-person event will feature podium talks, breakout sessions, a panel discussion, poster presentations, and more avenues to learn from and network with colleagues.
- August 03, 2024
Yale's new pilot program provides behavioral health care for patients with end-stage liver disease who are not eligible for transplant. The program provides sobriety support, mental health, and other behavioral health care to support the emotional and psychosocial needs of patients.
- July 29, 2024
On Yale Cancer Answers Dr. Tamar Taddei discusses the causes of liver disease and liver cancer and the multidisciplinary approaches to care.
- July 17, 2024
A new study by Yale researchers looked at how different ways of formatting the text of the Hepatitis C Virus guideline improved the accuracy of a large language model (LLM) so it could be more useful to clinicians.
- June 28, 2024
Inflammatory bowel disease, or IBD, is an umbrella term for conditions that cause chronic inflammation in the digestive system, leading to abdominal cramps and pain, diarrhea, and other symptoms. Patients with IBD will receive a diagnosis of ulcerative colitis, where inflammation damages the rectum and inner lining of the colon, or Crohn’s disease, which may cause inflammation in any part of the digestive tract. Together, these conditions affect about 1.5 million in the United States. Jill Gaidos, MD, associate professor of medicine (digestive diseases), medical director of the Yale Inflammatory Bowel Disease Program, and vice chief of clinical research (digestive diseases), shares more about the disease, new treatment options for patients, and other considerations for caring for patients with IBD.
- June 11, 2024
Faculty from across the Yale Department of Internal Medicine are using artificial intelligence (AI) as a tool to help improve the way they learn, teach, conduct research, and advance the field of medicine.
- June 03, 2024
Meet Glenn Belinsky, a research associate in the Section of Digestive Diseases, who studies risk factors for Parkinson’s disease in patients with Gaucher disease.
- May 29, 2024
Endoscopic retrograde cholangiopancreatography (ERCP) is a procedure physicians use to examine the pancreatic or bile ducts utilizing a combination of endoscopy and fluoroscopy to capture X-ray images of the ducts. Unfortunately, this procedure is not without risks. After undergoing ERCP, patients are typically observed for one hour before discharge. Post-ERCP pancreatitis, the most common adverse complication, can occur after discharge. A newly published Yale-led study, “Clinical Predictive Value of Renalase in Post-ERCP Pancreatitis,” aims to assess whether a patient's renalase level influences the development of pancreatitis following an ERCP procedure.